Autolus Therapeutics plc Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Autolus Therapeutics plc quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Autolus Therapeutics plc Operating Income (Loss) for the quarter ending September 30, 2024 was -$67.9M, a 58.2% decline year-over-year.
  • Autolus Therapeutics plc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$219M, a 39.2% decline year-over-year.
  • Autolus Therapeutics plc annual Operating Income (Loss) for 2023 was -$180M, a 25.3% decline from 2022.
  • Autolus Therapeutics plc annual Operating Income (Loss) for 2022 was -$143M, a 1.67% decline from 2021.
  • Autolus Therapeutics plc annual Operating Income (Loss) for 2021 was -$141M, a 16.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$180M -$36.3M -25.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$143M -$2.36M -1.67% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$141M +$27.1M +16.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 -$168M -$22.1M -15.1% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 -$146M -$88.5M -154% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-10
2018 -$57.5M -$34.1M -146% Oct 1, 2017 Sep 30, 2018 20-F 2020-03-03
2017 -$23.4M Oct 1, 2016 Sep 30, 2017 20-F 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.